Biotech | November 18, 2021
US govt signs deal with GSK and Vir Biotechnology to buy sotrovimab, a Covid-19 treatment
The final data from the trial showed sotrovimab reduces hospitalisation and risk of death by 79% in adults with mild-to-moderate Covid-19 who are at high risk of progression to severe disease
